These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 11980699

  • 1. On the mechanisms by which human apolipoprotein A-II gene variability relates to hypertriglyceridemia.
    Julve J, Blanco-Vaca F, Carles Escolà-Gil J.
    Circulation; 2002 Apr 30; 105(17):e129; author reply e129. PubMed ID: 11980699
    [No Abstract] [Full Text] [Related]

  • 2. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S, Goldberg IJ, Bruce C, Rubin E, Breslow JL, Tall A.
    J Clin Invest; 1994 Dec 30; 94(6):2457-67. PubMed ID: 7989603
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
    Aalto-Setälä K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg HN, Breslow JL.
    J Clin Invest; 1992 Nov 30; 90(5):1889-900. PubMed ID: 1430212
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice.
    Shachter NS, Hayek T, Leff T, Smith JD, Rosenberg DW, Walsh A, Ramakrishnan R, Goldberg IJ, Ginsberg HN, Breslow JL.
    J Clin Invest; 1994 Apr 30; 93(4):1683-90. PubMed ID: 8163669
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Apolipoprotein A-II/A-I ratio is a key determinant in vivo of HDL concentration and formation of pre-beta HDL containing apolipoprotein A-II.
    Pastier D, Dugué S, Boisfer E, Atger V, Tran NQ, van Tol A, Chapman MJ, Chambaz J, Laplaud PM, Kalopissis AD.
    Biochemistry; 2001 Oct 16; 40(41):12243-53. PubMed ID: 11591143
    [Abstract] [Full Text] [Related]

  • 9. Genomic interval engineering of mice identifies a novel modulator of triglyceride production.
    Zhu Y, Jong MC, Frazer KA, Gong E, Krauss RM, Cheng JF, Boffelli D, Rubin EM.
    Proc Natl Acad Sci U S A; 2000 Feb 01; 97(3):1137-42. PubMed ID: 10655497
    [Abstract] [Full Text] [Related]

  • 10. Importance of apo E2 heterozygosity, insulin, and hypertriglyceridemia for very low density lipoproteins.
    Ozçürümez M, Westphal S, Nauck M, Wieland H, Luley C.
    Atherosclerosis; 1997 Jul 25; 132(2):255-7. PubMed ID: 9242973
    [No Abstract] [Full Text] [Related]

  • 11. Genetic epistasis in the VLDL catabolic pathway is associated with deleterious variations on triglyceridemia in obese subjects.
    Brisson D, St-Pierre J, Santuré M, Hudson TJ, Després JP, Vohl MC, Gaudet D.
    Int J Obes (Lond); 2007 Aug 25; 31(8):1325-33. PubMed ID: 17342071
    [Abstract] [Full Text] [Related]

  • 12. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
    Ebara T, Ramakrishnan R, Steiner G, Shachter NS.
    J Clin Invest; 1997 Jun 01; 99(11):2672-81. PubMed ID: 9169497
    [Abstract] [Full Text] [Related]

  • 13. Association between apolipoprotein A2 MspI polymorphism and hypertriglyceridemia in Koreans.
    Hong SH, Kang BY, Park WH, Kim JQ, Lee CC.
    Hum Biol; 1998 Feb 01; 70(1):41-6. PubMed ID: 9489233
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Endogenous hypertriglyceridemia].
    Tsukamoto K.
    Nihon Rinsho; 2013 Sep 01; 71(9):1584-9. PubMed ID: 24205718
    [Abstract] [Full Text] [Related]

  • 16. Artemisia Iwayomogi Extract Attenuates High-Fat Diet-Induced Hypertriglyceridemia in Mice: Potential Involvement of the Adiponectin-AMPK Pathway and Very Low Density Lipoprotein Assembly in the Liver.
    Lee J, Narayan VP, Hong EY, Whang WK, Park T.
    Int J Mol Sci; 2017 Aug 12; 18(8):. PubMed ID: 28805698
    [Abstract] [Full Text] [Related]

  • 17. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V, Sánchez-Quesada JL, Antón R, Camacho M, Julve J, Escolà-Gil JC, Vila L, Ordóñez-Llanos J, Blanco-Vaca F.
    Circ Res; 2004 Oct 15; 95(8):789-97. PubMed ID: 15388641
    [Abstract] [Full Text] [Related]

  • 18. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.
    Ribas V, Palomer X, Roglans N, Rotllan N, Fievet C, Tailleux A, Julve J, Laguna JC, Blanco-Vaca F, Escolà-Gil JC.
    Biochim Biophys Acta; 2005 Dec 15; 1737(2-3):130-7. PubMed ID: 16226489
    [Abstract] [Full Text] [Related]

  • 19. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
    Chroni A, Kan HY, Kypreos KE, Gorshkova IN, Shkodrani A, Zannis VI.
    Biochemistry; 2004 Aug 17; 43(32):10442-57. PubMed ID: 15301543
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.